Abstract:Abstract Background The muscle mass of tumor patients could significantly affect the prognosis of patients. Urea-creatinine ratio (UCR) was considered related to skeletal muscle catabolism. The objective of this study was to investigate the ability of preoperative UCR to predict postoperative long-term prognosis and to verify the relationship between UCR and muscle mass in colorectal cancer patients. Method 221 patients with colorectal cancer underwent surgery in the study. Univariate and multivariate logistic analyses were used to determine the risk factors for long-term prognosis. The receiver operating characteristic curve (ROC) was plotted to determine the optimal prognostic cut-off value of UCR. The patients were divided into two groups according to the cut-off value to explore the relationship between UCR and the long-term prognosis of colorectal cancer patients. The same approach was used for subgroup analysis of patients with stage III tumors. Correlation analysis was implemented between the patient's preoperative UCR and the muscle parameters of the L3 cross-section scanned by CT. Results 221 patients were included from January 2015 to January 2019. Among them, 22 died, and 29 relapsed within 3 years. Multivariate analysis showed that age, BMI, serum creatinine (Scr), UCR, and tumor stage were associated with postoperative overall survival (OS) and relapse-free survival (RFS) (P<0.05). The area under the ROC for predicting 3-year overall survival and recurrence was 0.789 (95%CI: 0.691-0.888, p<0.001), 0.739 (95%CI: 0.581-0.847, p<0.001) in all patients respectively, and in stage III patients were 0.704 (95%CI:0.581-0.826, p=0.007), 0.709 (95%CI:0.595-0.824, p=0.003) respectively. Compared with the UCR low group stratified by a cut-off value of 2.65, the UCR high group had increased risk both for death 0.704 (95%CI:0.581-0.826, p=0.007) and recurrence (0.709 (95%CI:0.595-0.824, p=0.003). In addition, UCR level was significantly associated with skeletal muscle mass (R 2 =0.320, p<0.01). Conclusion UCR level could effectively predict the long-term prognosis of patients with colorectal cancer after surgery. Patients with UCR above 2.65 had an increased risk of death and tumor recurrence. Moreover, UCR was positively associated with skeletal muscle mass.

Creatinine-to-cystatin C Ratio As a Marker of Skeletal Muscle Mass for Predicting Postoperative Complications in Patients Undergoing Gastric Cancer Surgery.

IDDF2020-ABS-0159 A New Diagnostic Index of Skeletal Muscle Mass for Predicting Short-Term Postoperative Complications in Crohn’s Disease

Preoperative Controlling Nutritional Status (CONUT) Score Predicts Short-Term Outcomes of Patients with Gastric Cancer after Laparoscopy-Assisted Radical Gastrectomy

Preoperative Computed Tomography-Assessed Skeletal Muscle Index is a Novel Prognostic Factor in Patients with Hepatocellular Carcinoma Following Hepatectomy: a Meta-Analysis.

Change in Urea to Creatinine Ratio is Associated with Postoperative Complications and Skeletal Muscle Wasting in Pancreatic Cancer Patients Following Pancreatoduodenectomy.

Postoperative Ratio of C-Reactive Protein to Albumin As a Predictive Marker in Patients with Crohn’s Disease Undergoing Bowel Resection

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer

Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer

Prognostic Value of Myosteatosis and Creatinine-to-Cystatin C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery

Associations of creatinine/cystatin C ratio and postoperative pulmonary complications in elderly patients undergoing off-pump coronary artery bypass surgery: a retrospective study

Preoperative C-reactive Protein/albumin Ratio to Predict Mortality and Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker

Preoperative Serum Cystatin-C As a Potential Biomarker for Prognosis of Renal Cell Carcinoma.

The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis

Urea-creatinine ratio (UCR) predicts the long-term prognosis of colorectal cancer patients after surgery

C-Reactive Protein/Albumin Ratio on the First Day after Surgery Predicts Short-Term Complications of Gastrectomy for Gastric Cancer

Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker

A New Diagnostic Index for Sarcopenia and Its Association with Short-Term Postoperative Complications in Patients Undergoing Surgery for Colorectal Cancer.

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer